These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 33399851)
1. Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases. Sharma RK; Li J; Krishnan S; Richards EM; Raizada MK; Mohandas R Clin Sci (Lond); 2021 Jan; 135(1):1-17. PubMed ID: 33399851 [TBL] [Abstract][Full Text] [Related]
2. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients. Rahman MM; Hasan M; Ahmed A Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease. Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791 [TBL] [Abstract][Full Text] [Related]
5. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019. Suh SH; Ma SK; Kim SW; Bae EH Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712 [TBL] [Abstract][Full Text] [Related]
7. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression. Zlacká J; Stebelová K; Zeman M; Herichová I Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351 [TBL] [Abstract][Full Text] [Related]
8. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662 [TBL] [Abstract][Full Text] [Related]
9. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract. Galanopoulos M; Doukatas A; Gazouli M World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196 [TBL] [Abstract][Full Text] [Related]
10. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice. Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370 [TBL] [Abstract][Full Text] [Related]
11. Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2. Elrashdy F; Redwan EM; Uversky VN Infect Genet Evol; 2020 Nov; 85():104510. PubMed ID: 32853823 [TBL] [Abstract][Full Text] [Related]
12. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. Cheng H; Wang Y; Wang GQ J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983 [TBL] [Abstract][Full Text] [Related]
13. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney. Jiang X; Eales JM; Scannali D; Nazgiewicz A; Prestes P; Maier M; Denniff M; Xu X; Saluja S; Cano-Gamez E; Wystrychowski W; Szulinska M; Antczak A; Byars S; Skrypnik D; Glyda M; Król R; Zywiec J; Zukowska-Szczechowska E; Burrell LM; Woolf AS; Greenstein A; Bogdanski P; Keavney B; Morris AP; Heagerty A; Williams B; Harrap SB; Trynka G; Samani NJ; Guzik TJ; Charchar FJ; Tomaszewski M Eur Heart J; 2020 Dec; 41(48):4580-4588. PubMed ID: 33206176 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Datta PK; Liu F; Fischer T; Rappaport J; Qin X Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2, ACE2 expression, and systemic organ invasion. Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
17. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression. Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542 [TBL] [Abstract][Full Text] [Related]